This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Aug 2012

Scottish Biotech Aquapharm Discovers Novel Antibiotic Compound

Aquapharm Biodiscovery believes the marine-derived compound AQP-182 could help to tackle multi-drug resistant bacteria.

Aquapharm Biodiscovery, a biotechnology company specialising in the discovery and development of marine-derived bioactives, has identified a novel antibiotic compound.


The compound, AQP-182, was idenfitied from the Scottish company's collection of more than 10,000 marine micro-organisms.


Data indicate that it may be effective against a wide range of multi-drug resistant bacteria, including multi-drug resistant Staphylococcus aureus (MDRSA) and multi-drug resistant Streptococcus pneumoniae (MDRSP), along with Clostridium difficile and Enterococcus faecalis.


The compound is now in pre-clinical development and could play an important

Related News